OncoDNA NTRK Gene Fusion Assay

OncoDNA has released its OncoNTRK assay for solid or liquid biopsies analysis of tumors with potential NTRK gene fusions. According to the firm, the assay is the first commercial kit available for NTRK 1, 2, and 3 gene fusion profiling based on RNA-sequencing. OncoDNA said that the assay is particulary interesting for use in non-small cell lung cancer, pediatric glioblastoma, and thyroid cancer.